HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 09, September 2020 – 3D Technology: Additive Manufacturing Applications and Prospects       » Results of CD30 CAR-T Cell Therapy Trial Shows Promise for Hodgkin Lymphoma Patients       » Emerging Technologies and Innovations amid a Global Pandemic       » Monitoring COVID-19 Patients with AI-powered Platform       » Singapore Researchers Devise a Rapid COVID-19 Test Kit for the Detection of Neutralising Antibodies (NAbs) Against SARS-CoV-2       » Novel Ventilator Conceptualized by Singapore Clinicians Provides Efficient and Personalized Breathing Support for COVID-19 patients      
Vol 20, No. 04, April 2016   |   Issue PDF view/purchase
EDITOR'S LETTER
 

As you know, 4th February is the World Cancer Day, a wonderful day to unite global citizen in fighting against cancer. To contribute our little effort, we thought of having a special issue attributed to different types of cancer.

In this issue, APBN touches on how we declare war on cancer via the advances in radiation oncology and immunotherapy. On the other hand, we introduce Cancer Science Institute of Singapore (CSI) which aims to address the gap of knowledge on Asian cancers, and focuses its research on developing novel diagnosis and therapeutics for cancer types prevalent in Asia. Which approaches should we take to improve overall survival in hepatocellular carcinoma? Do you think the cervical cancer and colorectal carcinomas could be prevented? What should you know about immunotherapy? Check out our Features section to learn about them.

I am glad to have a lovely conversation with Dr. Rebecca Dent during 5th Asia Pacific Breast Cancer Summit and it was recorded in our Spotlights section. In the very same section, we also feature eminent biotech scientists from ASLAN to learn how they target on developing innovative therapies for rare tumour types in Asia and their future plans. Dr. Ravindran, an geriatric oncologist shares his views on the rising number of elderly cancer patients in Asia.

Turning our spotlight to China, a recent breakthrough news from Dr. Qiu Zilong’s lab in Chinese Academy of Sciences, which has successfully established a MECP2 transgenic monkey model with autism-like behaviour.

With the joint efforts of our art designer Lionel Seow, APBN writer Catherine D. Ong, website designer Annie Phua, and also other freelance editors, this Oncology issue has fallen into place, which we really hope you enjoy reading. Last but not least, feel free to write to us for any comments and feedback at biotech_edit@wspc.com. We will be glad to hear from you.

Thank you.

Carmen, Jia Wen Loh
APBN Editor
NEWS CRUNCH  
news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy